Brokers and banks usually stop taking bids earlier. Check the exact time with yours.
Total Issue Size
Fresh Issue + Offer For Sale
Fresh Issue (FI)
Proceeds go to the company
Offer For Sale (OFS)
Proceeds go to the existing investors
Capital Expenditure for Bavla Facility
Part funding the capital expenditure towards setting up a new manufacturing unit for sodium metabisulphite, sodium bisulphite powder, and ammonium bisulphite at Bavla, Ahmedabad, Gujarat.
General Corporate Purposes
Funding routine administrative, operational, and corporate requirements of the business.
(₹ in Crore)
Tap a bar to highlight a metric across periods and show its values.
No peer comparisons added yet.
Shanti Inorganics Limited, established in 2010 and previously operating as Shanti Inorgo Chem (Guj) Private Limited, is an Indian chemical manufacturing company. The organization specializes in the production and commercial trading of sulphur-based inorganic chemicals. Its primary product portfolio includes sodium metabisulphite, sodium bisulphite powder, sodium sulphite, and ammonium bisulphite solution, catering to diverse industrial applications. The company's products serve essential roles across multiple end-user sectors, including food and beverages, pharmaceuticals, oil drilling, water treatment, agrochemicals, and industrial processing. Operating out of Gujarat, the firm maintains two operational manufacturing units located in Vatva and Bavla near Ahmedabad. Shanti Inorganics has steadily expanded its market footprint, serving both domestic clients and international buyers across more than fifteen countries, with exports contributing a significant portion of overall revenue. To support future business growth, the company is undertaking a greenfield expansion project at its Bavla site to substantially enhance its chemical manufacturing capacity. The expansion aims to address rising demand for sulphur-derived inorganic salts in both domestic and global markets. Shanti Inorganics focuses on operational safety, quality management, and strategic raw material procurement to sustain its market position.
Shanti Inorganics raised Rs 13.44 crore from anchor investors on August 28, 2026, allocating 16,19,200 equity shares at Rs 83 per share to institutional investors.
Source: RHP • Analysis provided for informational purposes
Last Updated: 2 September 2026, 12:42 PM
Established Manufacturing Operations and Geographical Reach
The company operates two production facilities in Gujarat with capacity for sulphur-based inorganic salts, exporting products to over fifteen countries alongside domestic sales.
Diversified Customer Base Across Multiple Sectors
Products serve diverse end-user industries including pharmaceuticals, food and beverages, oil drilling, water treatment, and agrochemicals, mitigating sector-specific risks.
Strategic Greenfield Capacity Expansion
Setting up a new manufacturing plant at Bavla, Gujarat, aims to expand production capacity for core bisulphite and sulphite compounds to meet rising market demand.
Revenue Concentration Among Top Customers
A substantial portion of total revenue is derived from key client accounts without long-term supply contracts, exposing revenues to customer loss or reduced orders.
Raw Material Price and Supply Volatility
Operations rely heavily on sulphur and chemical raw material inputs, making profit margins susceptible to commodity price swings and supply disruptions.
Capital Outlay and Project Execution Risks
The greenfield facility construction at Bavla requires significant capital expenditure and faces potential risks of delay, cost overruns, or operational ramp-up challenges.
Shanti Inorganics Limited
No financial information whatsoever published anywhere, within this website, should be considered as an advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on information published on this website. The information on this website is based on information available as on date coupled with market perceptions.
You agree with the terms and conditions to use this website.
Grey-market disclaimer. GMP shown here is grey-market news only. We do not trade or deal in the grey market or subject-to rates, nor do we recommend trading in the grey market.
Not investment advice. IPO Nex is an information tool, not investment advice. We do not recommend buying or selling any securities. Always do your own research before applying to any IPO.
IPO Nex does not guarantee any listing gain or return. IPO investments are subject to market risks.
All times are IST.
© 2026 IPO Nex by Niota. All rights reserved.